Health Canada has approved Singulair (montelukast sodium) for the relief of symptoms of allergic rhinitis in people ages 15 and older. Allergic rhinitis, also known as hay fever, affects 20 percent to 25 percent of people in Canada and up to 75 percent of people with asthma. If poorly managed, the condition can increase the likelihood of asthma attacks and asthma-related hospital visits.
Read moreThe National High Blood Pressure Education Program is an association that consist of professional, public, voluntary and federal agencies.... Read more »
When it comes to finding financial assistance in paying for expensive medications, the process is not often an easy one. Many of the... Read more »
This is a study to evaluate the treatment of patients entering emergency rooms with asthma attacks when they are given an intravenous form of MK0476... Read more »
This is a study to determine if patients entering an emergency room with asthma attacks might benefit from an IV dose of an approved drug with the... Read more »
Source: Harvard Decision Guide
Prevention You can help prevent attacks of hay fever by reducing your exposure to the suspected allergens. It helps to: Stay indoors as much... Read more »
Source: ADAM Encyclopedia
Long-Term Relief MedicationsThese medications are taken on a regular basis to prevent asthma attacks and control chronic symptoms.Inhaled... Read more »
Source: ADAM Encyclopedia
Long-Term Relief MedicationsThese medications are taken on a regular basis to prevent asthma attacks and control chronic symptoms.Inhaled... Read more »